Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer. A trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG)

Phase Ii Study ◽

Small Cell ◽

Epirubicin in extensive small-cell lung cancer: A phase II study in previously untreated patients: A National Cancer Institute of Canada Clinical Trials Group Study

Lung Cancer ◽

10.1016/0169-5002(90)90224-a ◽

1990 ◽

Vol 6 (3-4) ◽

pp. 139

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Randomised phase II study of BMS-275291 versus placebo in patients (pts) with stage IIIb or IV non small cell lung cancer (NSCLC) receiving paclitaxel + carboplatin (PC): National Cancer Institute of Canada clinical trials group (NCIC CTG) br.18

European Journal of Cancer ◽

10.1016/s0959-8049(01)80555-4 ◽

2001 ◽

Vol 37 ◽

pp. S19-S20 ◽

Cited By ~ 6

Author(s):

J. Douillard ◽

V. Petersen ◽

F. Shepherd ◽

L. Paz-Ares ◽

A. Arnold ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iiib ◽

Phase II study of acivicin in non-small cell lung cancer: A national cancer institute of Canada study

Lung Cancer ◽

10.1016/s0169-5002(87)80103-4 ◽

1987 ◽

Vol 3 (2) ◽

pp. 100-101

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group

Lung Cancer ◽

10.1016/0169-5002(95)00600-1 ◽

1996 ◽

Vol 15 (3) ◽

pp. 367-373 ◽

Cited By ~ 14

Author(s):

J. Viallet ◽

D. Stewart ◽

F. Shepherd ◽

J. Ayoub ◽

Y. Cormier ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Previously Treated

Erratum to “Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group” [Lung Cancer 15 (1996) 367–373]

Lung Cancer ◽

10.1016/s0169-5002(97)00667-3 ◽

1997 ◽

Vol 17 (1) ◽

pp. 179

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Previously Treated

Weekly vinorelbine and paclitaxel in elderly patients with advanced non-small cell lung cancer: A Fred and Pamela Buffett Cancer Center Clinical Trials Network phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e19016 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e19016-e19016

Author(s):

Mary Mereta Huerter ◽

M. Anne Kessinger ◽

Addison R. Tolentino ◽

Mehmet Sitki Copur ◽

Holly Despiegelaere ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Cancer Center ◽

Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non[ndash ]small cell lung cancer

Seminars in Oncology ◽

10.1053/sonc.2001.27610 ◽

2001 ◽

Vol 28 (4L) ◽

pp. 14-16

Author(s):

Chandra P. Belani

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Interim Analysis ◽

Phase Ii Study ◽

Small Cell ◽

Weekly Paclitaxel ◽

Faculty of 1000 evaluation for A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717976259.793472648 ◽

2013 ◽

Author(s):

James Spicer

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Initial Treatment ◽

Phase Ii Study ◽

Small Cell ◽

A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2006.06.013 ◽

2006 ◽

Vol 54 (1) ◽

pp. 57-62 ◽

Cited By ~ 14

Author(s):

Jung Han Kim ◽

Dong Hun Lee ◽

Hyun Chun Shin ◽

Jung Hye Kwon ◽

Joo Young Jung ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Split Dose

115P Survival data from EMPOWER-Lung 4: Phase II study of cemiplimab plus ipilimumab in the second-line (2L) treatment of advanced non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01957-2 ◽

2021 ◽

Vol 16 (4) ◽

pp. S760

Author(s):

B.Y. Shim ◽

S. Lee ◽

J. de Castro Carpeño ◽

C-H. Chiu ◽

M. Cobo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Survival Data ◽

Phase Ii Study ◽

Small Cell ◽

Second Line ◽